Kazia Therapeutics Limited

ASX:KZA 株式レポート

時価総額:AU$18.9m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Kazia Therapeutics マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

John Friend

最高経営責任者

AU$1.6m

報酬総額

CEO給与比率47.1%
CEO在任期間less than a year
CEOの所有権n/a
経営陣の平均在職期間less than a year
取締役会の平均在任期間1.3yrs

経営陣の近況

Recent updates

We're Not Worried About Kazia Therapeutics' (ASX:KZA) Cash Burn

Jun 24
We're Not Worried About Kazia Therapeutics' (ASX:KZA) Cash Burn

We're Not Worried About Kazia Therapeutics' (ASX:KZA) Cash Burn

Feb 24
We're Not Worried About Kazia Therapeutics' (ASX:KZA) Cash Burn

We Take A Look At Why Kazia Therapeutics Limited's (ASX:KZA) CEO Compensation Is Well Earned

Nov 03
We Take A Look At Why Kazia Therapeutics Limited's (ASX:KZA) CEO Compensation Is Well Earned

We Think Kazia Therapeutics (ASX:KZA) Can Easily Afford To Drive Business Growth

Sep 23
We Think Kazia Therapeutics (ASX:KZA) Can Easily Afford To Drive Business Growth

We Think Kazia Therapeutics (ASX:KZA) Can Afford To Drive Business Growth

May 04
We Think Kazia Therapeutics (ASX:KZA) Can Afford To Drive Business Growth

When Will Kazia Therapeutics Limited (ASX:KZA) Turn A Profit?

Mar 27
When Will Kazia Therapeutics Limited (ASX:KZA) Turn A Profit?

Could The Kazia Therapeutics Limited (ASX:KZA) Ownership Structure Tell Us Something Useful?

Feb 28
Could The Kazia Therapeutics Limited (ASX:KZA) Ownership Structure Tell Us Something Useful?

What Can We Learn About Kazia Therapeutics' (ASX:KZA) CEO Compensation?

Feb 01
What Can We Learn About Kazia Therapeutics' (ASX:KZA) CEO Compensation?

We Think Kazia Therapeutics (ASX:KZA) Can Afford To Drive Business Growth

Jan 06
We Think Kazia Therapeutics (ASX:KZA) Can Afford To Drive Business Growth

Bullish: Analysts Just Made An Incredible Upgrade To Their Kazia Therapeutics Limited (ASX:KZA) Forecasts

Dec 11
Bullish: Analysts Just Made An Incredible Upgrade To Their Kazia Therapeutics Limited (ASX:KZA) Forecasts

Kazia Therapeutics Limited (ASX:KZA): When Will It Breakeven?

Nov 26
Kazia Therapeutics Limited (ASX:KZA): When Will It Breakeven?

CEO報酬分析

Kazia Therapeutics の収益と比較して、John Friend の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2023AU$2mAU$743k

-AU$20m

Mar 31 2023n/an/a

-AU$23m

Dec 31 2022n/an/a

-AU$25m

Sep 30 2022n/an/a

-AU$25m

Jun 30 2022AU$1mAU$430k

-AU$25m

報酬と市場: Johnの 総報酬 ($USD 1.03M ) は、 Australian市場 ($USD 296.24K ) の同規模の企業の平均を上回っています。

報酬と収益: Johnの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

John Friend (53 yo)

less than a year

在職期間

AU$1,576,913

報酬

Dr. John E. Friend, II, M. D., serves as Chief Executive Officer at Kazia Therapeutics Limited since May 01, 2023 and since August 1, 2023 serves as Managing Director and Director and served as Chief Medic...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
John Friend
CEO, MD & Interim Chairmanless than a yearAU$1.58mデータなし
Karen Krumeich
Chief Financial Officer1.8yrsAU$1.05mデータなし
Anna Sandham
Company Secretaryless than a yearデータなしデータなし

0.8yrs

平均在職期間

経験豊富な経営陣: KZAの経営陣は 経験豊富 とはみなされません ( 0.8年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
John Friend
CEO, MD & Interim Chairmanless than a yearAU$1.58mデータなし
Bryce Carmine
Independent Non-Executive Director8.4yrsAU$94.00k0.36%
A$ 68.5k
Patrick Wen
Member of Scientific Advisory Board1.3yrsデータなしデータなし
Steven Coffey
Independent Non-Executive Director11yrsAU$94.00k0.42%
A$ 79.4k
Ebru Davidson
Directorless than a yearAU$7.12kデータなし
Priscilla Brastianos
Member of Scientific Advisory Board1.3yrsデータなしデータなし
John de Groot
Member of Scientific Advisory Board1.3yrsデータなしデータなし
Alan Olivero
Member of Scientific Advisory Board1.3yrsデータなしデータなし

1.3yrs

平均在職期間

61yo

平均年齢

経験豊富なボード: KZAの 取締役会経験豊富 ではない ( 1.3年の平均在任期間) ため、新しい取締役会が必要であると考えられます。